Filing Flows › Companies › Teva Pharmaceutical Industries › Timeline
Teva Pharmaceutical Industries stock timeline
A year of the price with every insider trade, planned sale, earnings report and material 8-K marked
252 sessions+74.3% to $42.61
Teva Pharmaceutical Industries (TEVA) stock rose 74% over the last 252 sessions, to $42.61. On the way it reported 1 quarter, its insiders filed 23 open-market trades and 7 Form 144 notices of planned sales, and the company filed 3 material 8-Ks. Each is marked on the price and listed with what the stock did next.
Each mark, and what followed
| Date | Kind | What | Next session | 5 sessions | 21 sessions |
|---|---|---|---|---|---|
| Nov 5, 2026 | Form 144 | Form 144: Mark Sabag plans to sell $1.9M | −0.2% (+4.3% vs SPY) | — | — |
| Nov 5, 2026 | Insider sale | Sabag Mark sold $1.9M | −0.2% (+4.3% vs SPY) | — | — |
| Nov 4, 2026 | Form 144 | Form 144: Dov Bergwerk plans to sell $1.1M | −0.1% (−1.8% vs SPY) | — | — |
| Nov 4, 2026 | Insider sale | Bergwerk Dov sold $730K | −0.1% (−1.8% vs SPY) | — | — |
| Nov 3, 2026 | Earnings | Earnings: beat the EPS estimate by 19.3% | +2.9% (+2.6% vs SPY) | — | — |
| Oct 29, 2026 | 8-K | Directors and officers: departures, appointments, pay | +1.5% (+3.3% vs SPY) | +0.7% (+5.6% vs SPY) | — |
| Sep 18, 2026 | Form 144 | Form 144: Bridger Management, LLC (1) plans to sell $14.4M | −0.5% (−0.7% vs SPY) | +2.6% (+1.7% vs SPY) | +5.7% (+5.4% vs SPY) |
| Sep 18, 2026 | Form 144 | Form 144: Brian Savage plans to sell $273K | −0.5% (−0.7% vs SPY) | +2.6% (+1.7% vs SPY) | +5.7% (+5.4% vs SPY) |
| Sep 18, 2026 | Insider sale | Savage Brian sold $285K | −0.5% (−0.7% vs SPY) | +2.6% (+1.7% vs SPY) | +5.7% (+5.4% vs SPY) |
| Sep 18, 2026 | Insider sale | Mignone Roberto sold $14.4M | −0.5% (−0.7% vs SPY) | +2.6% (+1.7% vs SPY) | +5.7% (+5.4% vs SPY) |
| Sep 16, 2026 | 8-K | Material definitive agreement | +1.7% (+0.6% vs SPY) | +1.2% (−0.8% vs SPY) | +6.5% (+3.9% vs SPY) |
| Aug 21, 2026 | Insider sale | Weiss Amir sold $355K | +1.4% (+1.0% vs SPY) | +2.2% (+1.1% vs SPY) | +8.5% (+6.8% vs SPY) |
| Aug 21, 2026 | Insider sale | Satchi-Fainaro Ronit sold $15K | +1.4% (+1.0% vs SPY) | +2.2% (+1.1% vs SPY) | +8.5% (+6.8% vs SPY) |
| Aug 17, 2026 | Form 144 | Form 144: Evan Lippman plans to sell $680K | −0.8% (−0.4% vs SPY) | +1.5% (+2.9% vs SPY) | +6.5% (+9.0% vs SPY) |
| Aug 3, 2026 | Form 144 | Form 144: Placid Jover plans to sell $447K | −1.6% (−3.0% vs SPY) | +1.0% (−2.4% vs SPY) | +2.9% (+0.3% vs SPY) |
| Aug 3, 2026 | Form 144 | Form 144: Eric A Hughes plans to sell $892K | −1.6% (−3.0% vs SPY) | +1.0% (−2.4% vs SPY) | +2.9% (+0.3% vs SPY) |
| Jun 18, 2026 | Insider sale | Shields Matthew sold $322K | −3.4% (−4.4% vs SPY) | +3.2% (+3.9% vs SPY) | −4.9% (−5.3% vs SPY) |
| May 6, 2026 | Insider sale | Weiss Amir sold $384K | +1.3% (0.0% vs SPY) | −0.1% (−2.1% vs SPY) | −4.1% (−8.6% vs SPY) |
| May 5, 2026 | Insider sale | Daniell Richard sold $1.1M | +1.4% (+0.6% vs SPY) | +1.4% (−1.5% vs SPY) | −7.4% (−12.3% vs SPY) |
| May 1, 2026 | Insider sale | Sabag Mark sold $5.0M | −0.3% (−0.6% vs SPY) | +2.7% (+0.9% vs SPY) | −1.2% (−6.6% vs SPY) |
| Apr 30, 2026 | Insider sale | Fox Christine sold $751K | −0.9% (−1.9% vs SPY) | +2.7% (−0.4% vs SPY) | −0.2% (−6.3% vs SPY) |
| Mar 17, 2026 | Insider sale | Sabag Mark sold $1.9M | +2.1% (+1.9% vs SPY) | −2.4% (−0.6% vs SPY) | +7.1% (+2.3% vs SPY) |
| Mar 5, 2026 | Insider sale | Savage Brian sold $36K | −3.6% (−3.0% vs SPY) | −7.7% (−6.4% vs SPY) | −9.0% (−4.9% vs SPY) |
| Mar 4, 2026 | Insider sale | Savage Brian sold $87K | +1.9% (+1.2% vs SPY) | −2.4% (−1.9% vs SPY) | −6.5% (−3.0% vs SPY) |
| Mar 3, 2026 | Insider sale | Savage Brian sold $41K | −4.5% (−3.6% vs SPY) | −7.0% (−5.8% vs SPY) | −11.4% (−6.3% vs SPY) |
| Dec 16, 2025 | Insider sale | Weiss Amir sold $371K | −0.1% (+0.2% vs SPY) | +3.5% (+2.6% vs SPY) | +7.1% (+5.1% vs SPY) |
| Dec 16, 2025 | Insider sale | Mignone Roberto sold $2.3M | −0.1% (+0.2% vs SPY) | +3.5% (+2.6% vs SPY) | +7.1% (+5.1% vs SPY) |
| Dec 11, 2025 | 8-K | Material definitive agreement | −1.3% (−0.2% vs SPY) | +0.5% (+2.3% vs SPY) | +7.3% (+6.3% vs SPY) |
| Dec 9, 2025 | Insider sale | Sabag Mark sold $6.2M | +0.8% (+0.9% vs SPY) | +6.2% (+6.6% vs SPY) | +13.7% (+12.6% vs SPY) |
| Dec 9, 2025 | Insider sale | Daniell Richard sold $3.3M | +0.8% (+0.9% vs SPY) | +6.2% (+6.6% vs SPY) | +13.7% (+12.6% vs SPY) |
| Nov 26, 2025 | Insider sale | Mignone Roberto sold $1.3M | +5.2% (+4.5% vs SPY) | +10.8% (+9.5% vs SPY) | +24.4% (+21.9% vs SPY) |
| Nov 14, 2025 | Insider sale | Fox Christine sold $753K | −0.5% (−0.5% vs SPY) | −5.1% (−2.1% vs SPY) | +16.5% (+15.2% vs SPY) |
| Nov 6, 2025 | Insider sale | Weiss Amir sold $301K | −0.6% (+0.5% vs SPY) | +4.9% (+4.0% vs SPY) | +14.6% (+13.4% vs SPY) |
| Nov 6, 2025 | Insider sale | Mignone Roberto sold $4.8M | −0.6% (+0.5% vs SPY) | +4.9% (+4.0% vs SPY) | +14.6% (+13.4% vs SPY) |
Insiders’ record here
In the year on the chart, Teva Pharmaceutical Industries' insiders reported 0 open-market buys ($0) and 23 sales ($46.7M). Of the 17 old enough to score, 8 were followed by the stock doing what the trade implied over the next 63 sessions (beating SPY after a buy, lagging it after a sale); the median excess return after a buy was — and after a sale +0.6%.
Across the whole universe (19,782 scored trades), insider buys beat the market 46% of the time and sales were followed by a lagging stock 61% of the time; buys of $1M or more 39%. Every pattern →
What this kind of 8-K usually did
| Item | 8-Ks | Next session, median | Up next session | 21 sessions, median | Typical size |
|---|---|---|---|---|---|
| 1.01 Material definitive agreement | 23,525 | 0.0% | 51% | +1.0% | ±1.4% |
| 2.03 New debt or off-balance-sheet obligation | 13,268 | 0.0% | 50% | +1.2% | ±1.3% |
| 5.02 Directors and officers: departures, appointments, pay | 39,174 | −0.1% | 48% | +0.7% | ±1.4% |
Across every company in the move-odds universe, measured from the close before the filing. Every 8-K item ranked →
Teva Pharmaceutical Industries: every quarter → Live insider trades →
Prices are daily closes; filings and trades are as filed with the SEC (Form 4 within two business days of the trade, 8-K within four of the event). Moves after a mark are the stock's close-to-close change and the same for SPY; they describe the record, not what the next one will do. Not investment advice.